TAVR (TAVI)
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA, and Patrick McCarthy, Executive Director...
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with David Waller, Chair of the EACTS Emphysema Taskforce and Director of the EACTS Fundamentals Course in Thoracic Surgery, about...
In this discussion, CTSNet Senior Editor—Education Vincent Gaudiani, a Clinical Associate Professor of Cardiothoracic Surgery at Stanford University in Stanford, California, USA, and Chad Rammohan, an interventional and structural cardiologist...
This talk features Joseph Zacharias, a consultant cardiothoracic surgeon at the Lancashire Cardiac Center in Blackpool, England, delivering a presentation on “Can the Endoscope ‘Challenge’ the Catheter?” at the Endoscopic...
CTSNet hosted a webinar on September 15, 2026, titled “The TAVR Heart Team in 2026: Navigating the CMS Decision,” featuring leading surgeons Tom B. Nguyen, Michael Mack, and Tsuyoshi Kaneko,...
Aortic stenosis affects more than 9 million people worldwide and is commonly treated with surgical aortic valve replacement (SAVR), which is known for producing excellent long-term outcomes. Recent advancements in...
Treatment of aortic stenosis due to a bicuspid aortic valve (BAV), requires a lifetime strategy due to structural valve degeneration that necessitates redo intervention, such as surgical aortic valve replacement...
Transcatheter aortic valve replacement (TAVR) has surpassed surgical aortic valve replacements in volume since TAVR is now approved for patients of all surgical risk categories. This article evaluated trainees and...
In this large population-based cohort study, long-term mortality and morbidity were investigated in patients undergoing biological surgical aortic valve replacement (SAVR) or transcatheter aortic valve replacement (TAVR) for severe aortic...
The number of patients at intermediate and low surgical risk treated by transcatheter aortic valve implantation (TAVI) is rapidly increasing. Current guidelines recommend performing TAVI in heart valve centers with...
Surgical explantation of transcatheter heart valves (THV) is rapidly increasing, but data on patients with THV-associated infective endocarditis (IE) is lacking. This study assessed the outcomes of patients undergoing THV...
The NOTION-2 trial aimed to compare transcatheter aortic valve implantation (TAVI) with surgical aortic valve replacement (SAVR) in low-risk patients less than 75 years old, including with both tricuspid and...
This report presents trends and outcomes of cardiac surgery following initial transcatheter aortic valve replacement (TAVR). The Society of Thoracic Surgeons (STS) Adult Cardiac Surgery Database was queried for all...

